Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Sexuality 1Sexual Dysfunction, Physiological 1Radiation Injuries 1Prostatic Neoplasms 1Erectile Dysfunction 1

Interventions

Radiotherapy 38Radiotherapy, Intensity-Modulated 12Cisplatin 12Amifostine 11Paclitaxel 7Carboplatin 7Radiosurgery 6Etoposide 5Brachytherapy 5Surgical Procedures, Operative 4Low-Level Light Therapy 4Donepezil 4Chemotherapy, Adjuvant 4Bevacizumab 4sargramostim 3Surveys and Questionnaires 3Radiation 3Proton Therapy 3Neuropsychological Tests 3Mental Status and Dementia Tests 3Magnetic Resonance Spectroscopy 3Heavy Ion Radiotherapy 3Filgrastim 3Diet Therapy 3Chemoradiotherapy 3Blood Specimen Collection 3Radiotherapy, Conformal 2Radiation Dose Hypofractionation 2Patient Reported Outcome Measures 2Lithium 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Radiation Injuries × ArginMax × Clear all
NCT01105130 2021-09-28

L-Arginine Supplementation With or Without Enzyme Inhibitors Treating Erectile Function of Prostate Cancer Survivors

Wake Forest University Health Sciences

Phase 2 Completed
140 enrolled 13 charts
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡